aTYR PHARMA Inc · Brief

Next report

1 day

Nov 5 · after closeest.Q3 FY26

Expected move

No implied move.

8 reportsHistory

1 of 8≥ implied

Nov 7 '24±18.9%▲+0.65%×0.03

Mar 13 '25±30.5%▼−0.50%×0.02

May 7 '25±19.9%▲+5.70%×0.29

Q3 FY25±25.0%▲+6.05%×0.24

Q1 FY26±85.0%▼−8.68%×0.10

May 11 '26±13.4%▼−44.20%×3.29

May 15 '26±20.2%▼−9.98%×0.49

Q2 FY26±37.8%▲+3.42%×0.09

quarterimplied−85%0+85%realized×

Q2 FY26±37.8%▲+3.42%×0.09

May '26±20.2%▼−9.98%×0.49

May '26±13.4%▼−44.20%×3.29

Q1 FY26±85.0%▼−8.68%×0.10

Q3 FY25±25.0%▲+6.05%×0.24

May '25±19.9%▲+5.70%×0.29

2 older reports

Mar '25±30.5%▼−0.50%×0.02

Nov '24±18.9%▲+0.65%×0.03

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Nov 5 report · est.

Bull1

90managers reporting a position in the latest quarterly filings13F · Jun 30 '26

Bear2 of 3

7 of 8recent reports where the move came in under options implied rangeEarnings history

13 of 24of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26

AI captions · Sep 28 '26once per report · top 2 per case

ATYR report session

No linked exposure.

Oct 28haltTrading halt: 19:50 ET, resumed 09:00 ET.Source

Oct 22impliedImplied move: ±62.3% into Nov 5 earnings (Oct 22 close).Source

privateThesis 0 · Decisions 0 · Observations 0

No thesis.